Study IDs new type 2 diabetes marker

11/7/2012 | Medical News Today

People who have above-average levels of SFRP4 protein in their blood have a higher risk of developing type 2 diabetes compared with those with below-average levels, research published in Cell Metabolism found. The findings suggest SFRP4, which has a part in inflammatory processes, may serve as a marker for diabetes risk and may lead to the development of new diabetes treatments, researchers said.

View Full Article in:

Medical News Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA